Richard /ca/ Murray, Director at Jounce Therapeutics, Inc. (JNCE), sold 78,456 shares at $1.85 ($145K) on 2023-04-04, disclosed to the SEC on 2023-04-06.
Scheduled sale ($145k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.85 | 39,228 | $73K | 50.0% |
| 2 | $1.85 | 39,228 | $73K | 50.0% |
| Total | $1.85 avg | 78,456 | $145K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-25 | $808K | — | Filing → |
| JNCE | SELL | 2021-01-20 | $1.3M | — | Filing → |
| JNCE | SELL | 2021-01-11 | $220K | — | Filing → |